RBC Capital analyst Frank Morgan raised the price target on Amedisys (NASDAQ: AMED) to $100.00 (from $97.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE